Dr. Tolar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
420 Delaware Street SE
Minneapolis, MN 55455- Is this information wrong?
Summary
- I am a physician-scientist (pediatric hematology-oncology and bone marrow transplant surgeon) focused on finding new ways of treating children with lethal genetic diseases- like EB, Hurler syndrome and others.
In addition to my research and clinical care, I serve as Dean of the University of Minnesota Medical School and Vice President for Clinical Affairs at the University of Minnesota. I also serve as the Campus Public Health Officer for the U of M School system. I also serve as Board Chair for the University of Minnesota Physicians (M Physicians), a multi-specialty group practice for the University of Minnesota Medical School faculty. Lastly, I am the co-lead for our joint clinical enterprise, M Health Fairview.
Education & Training
- University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2000 - 2003
- University of MinnesotaResidency, Pediatrics, 1997 - 2000
- University of MinnesotaPh.D., Molecular, Cellular & Developmental Biology and Genetics, 1992 - 1996
- Charles University in Prague Faculty of MedicineClass of 1990, Summa Cum Laude
- Na Vitezne PlaniB.S., Examination of Maturity, Summa Cum Laude, 1980 - 1984
Certifications & Licensure
- MN State Medical License 1999 - 2024
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Best Doctors in America BestDoctors.com, 2012, 2017-2018
- Top Doctors Minneapolis St. Paul Magazine, 2010, 2012-2018
- Elected to Academic Health Center's Academy for Excellence in Health Research University of Minnesota, 2016
- Join now to see all
Clinical Trials
- Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
- HSCT for High Risk Inherited Inborn Errors Start of enrollment: 2006 Sep 01
- Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA Start of enrollment: 2007 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Beyond the Surface: A Narrative Review Examining the Systemic Impacts of Recessive Dystrophic Epidermolysis Bullosa.Courtney Popp, William Miller, Cindy Eide, Jakub Tolar, John A McGrath, Christen L Ebens> ;The Journal of Investigative Dermatology. 2024 Apr 12
- Methods for Decreasing Preweaning Mortality in a Fragile Mouse Model of Hypomorphic Collagen VII Deficiency.Chloe L Strege, William C Miller, Cindy Eide, Jennifer Hubbard, Jakub Tolar> ;Comparative Medicine. 2024 Mar 20
- Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice.Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor...> ;Blood. 2024 Mar 6
- Join now to see all
Journal Articles
- Thymic Epithelial Cell Support of Thymopoiesis Does Not Require KlothoBruce R Blazar, Heather E Stefanski, Sarah L Parker, Jakub Tolar, The Journal of Immunology
- Outcome of Haematopoietic Stem Cell Transplantation in Dyskeratosis Congenita*Jakub Tolar, MD, British Journal of Haematology
- Prediction of DNA-binding propensity of proteins by the ball-histogram methodSzaboova A, KuZelka O, Morales E, Zelezny F, Tolar J, Lect Notes Comput Sc, 1/1/2011
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Plasma and intracellular population pharmacokinetic analysis of fludarabine in pediatric allogeneic hematopoietic cell transplant (alloHCT) recipients.Long-Boyle J, Sambol N, Dvorak CC, Cowan MJ, Lee S, Huang LS, Horn B, Stricherz M, Tolar J, Orchard P, Jacobson P, Aweeka F, Biol Blood Marrow Transplant, 1/1/2014
- Toxic epidermal necrolysis (TEN) in recessive dystrophic epidermolysis bullosa status post hematopoietic stem cell transplant.Sajic D, Hook K, Tolar J, 89th Canadian Dermatology Association Annual Conference, 1/1/2014
- Effects of vitronectin on neural differentiation and proliferation of human iPSC’s in 3D cell culture.Venhuizen S, Lindborg B, Haider K, Ulrich C, Vegoe A, Subramaniam S, Brekke JH, Dutton J, Tolar J, O’Brien TD, Cornell University Merial-NIH Veterinary Scholars Symposium, 1/1/2014
- Join now to see all
Lectures
- Reduced Intensity Conditioned Bone Marrow Transplant with Post-Transplant Cyclophosphamide and Donor-Derived Mesenchymal Stromal Cell Infusions for Recessive Dystrophi...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Cellular Therapy: Concepts and PlansOsaka, Japan - 1/14/2014
- Immunity in Genetic Disorders, Cancer, and Bone Marrow TransplantUniversity of Minnesota Children’s Hospital, Minneapolis, MN - 1/11/2014
- Join now to see all
Press Mentions
- Supporting the U of M Enhances Rural Health Care AccessApril 19th, 2023
- U of M Wants $950 Million to Buy Health Care Facilities Before MergerFebruary 24th, 2023
- Vision for Improving Health in Greater MN Outlined to RegentsJanuary 20th, 2023
- Join now to see all
Professional Memberships
- American Association for the Advancement of ScienceMember
- American Society of TransplantationMember
- St. John's Dermatological SocietyMember
- Member
- Member
- Member
Other Languages
- Czech
Hospital Affiliations
- M Health Fairview Masonic Children’s HospitalMinneapolis, Minnesota
- M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: